
Brendan McAtamney
THE SURPRISE bid by US fund Clayton, Dubilier & Rice (CD&R) for UDG Healthcare may prove timely for investors given the sensitive area in which the Irish company operates. The promotion of presecription medicine is a legal minefield and could well end up being regulated out of existence. The arrival of Paul Singer – the... Read more »